Rising cancer prevalence is driving the global CAR T-cell therapy market, valued at USD 2.50 Billion in 2024. Growing at a CAGR of 15.20%, the market is projected to expand from USD 2.9 Billion in 2025 to USD 10.29 Billion by 2034, signaling rapid advancements in immunotherapy treatments. https://www.expertmarketresearch.com/reports/car-t-cell-therapy-market